Sanofi And Genzyme: Do Big Pharmas And Orphan Drugs Fit Together?
If successful, Sanofi-Aventis' attempt to acquire Genzyme would catapult the company into the orphan drug business, marking Big Pharma's most aggressive strategy in the space to date.
If successful, Sanofi-Aventis' attempt to acquire Genzyme would catapult the company into the orphan drug business, marking Big Pharma's most aggressive strategy in the space to date.